Phase II 'Proof of Concept' Trial Evaluating Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab in Combination With Chemotherapy in Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2018
At a glance
- Drugs Bevacizumab (Primary) ; Cyclophosphamide; Docetaxel; Epirubicin; Fluorouracil; Trastuzumab
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms AVASTEM
- 25 Jan 2018 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 19 Mar 2013 Planned end date changed from 1 May 2018 to 1 May 2017 as reported by ClinicalTrials.gov.